Endo Flashcards

1
Q

Describe the signs and symptoms of menopause

A

change in menstrual cycle
vasomotor sxs (hot flashes, night sweats)
vulvovaginal sxs (dryness) => painful sex
sleep disturbances
weight gain - 5 lbs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

menopause

A

stop period

after 12 months without period

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

perimenopause

A

1st signs of endocrine change
irregular period
ends 1 year after last period

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

natural/spontaneous menopause

A

12 months after last period confirmed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

induced menopause

A

stopped periods manually

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

peri-menopause - menopause transition

A

starts when you see sxs

ends 12 months after last period

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

post-menopause

A

years after last period

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

bioidentical hormone therapy (BHT)

A

v similar to hormones of the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

estrogen therapy (ET)

A

unopposed estrogen for:

  1. systemic use for women without uterus
  2. local for women with dryness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

estrogen-progestogen (EPT)

A

progestogen added to ET

protect women with uterus from endometrial cancer (estrogen can cause cancer)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

FDA approved indications for HT

A

Vasomotor sxs
prevention of bone loss
premature estrogen loss
genitourinary sxs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How can contraceptives help with perimenopause symptoms?

A
less hot flashes
more predictable period
less cramps
improve BMD
decrease risk cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the physiological effect of PTH

A

Bone: increase expression and secretion of RANK ligand from osteoblasts
RANKL causes osteoclast formation => bone resorption
Kidney: decrease phosphate transporter => decrease phosphate uptake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the physiological effect of calcitonin

A

increases cAMP to inhibit osteoclasts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the physiological effect of vitamin D

A

Bone: osteoblasts have Vit D receptors. Cause blasts to make cytokines that activate clasts to resorb Ca which make blasts deposit Ca. BONE MOBILIZING ACTION
Kidney: increase Ca reabsorption
Intestine: Increase Ca absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

List the causes of primary osteoporosis

A

aging, menopause, andropause

17
Q

list the causes of secondary osteoporosis

A

endocrine, liver/kidney disease, malignancies, malnutrition, GI disease (no Ca abs), genetic disease

18
Q

name the drugs used in treatment of osteoporosis

A
bisphosphonates
denosumab (Prolia)
estrogen/progestins & SERMs
calcitonin
teriparatide
abaloparatide
19
Q

MOA of bisphosphonates

A
  1. get deposited onto bone
  2. gets eaten by clast
  3. cause clast apoptosis
20
Q

MOA of Denosumab

A

decrease binding of RANKL to RANK so prevent clast formation and activation

21
Q

MOA of SERMs

A

Ex: raloxifene (Evista)

estrogen receptor agonist: decrease bone resorption

22
Q

MOA of calcitonin

A

activate G protein receptor on clasts
increase cAMP
inhibit clast

23
Q

MOA of estrogen/progestin

A

make less cytokines which activate clasts

estrogen bind to blast => decrease making RANKL => decrease clast activity

24
Q

MOA of teriparatide

A

low dose causes increase in blasts and bone formation

25
Q

MOA of abaloparatide

A

low dose causes increase in blasts and bone formation

26
Q

who should be tested for osteoporosis

A
women over 65
post menopause/perimenopause
men over 70
men 50-69 with risk factors
fracture after 50 years
condition/medication: glucocorticoids, RA
27
Q

Risk factors of osteoporosis

A
vit D deficient
hyperprolact
hyperPTH
Cushings
Diabetes
28
Q

Meds associated with osteoporosis

A

depo-medroxyprogesterone
thiazolidenediones
glucocorticoids
thyroid hormone

29
Q

T-scores

A
  • 1 and up: normal
  • 1 to -2.5: osteopenia
  • 2.5 and less: osteoporosis
  • 2.5 and less and hx of fracture: severe